Literature DB >> 27653163

Gastrointestinal defense mechanisms.

Hyder Said1, Jonathan D Kaunitz.   

Abstract

PURPOSE OF REVIEW: To summarize and illuminate the recent findings regarding gastroduodenal mucosal defense mechanisms and the specific biomolecules involved in regulating this process, such as glucagon-like peptides (GLPs). RECENT
FINDINGS: There has been a growing interest in luminal nutrient chemosensing and its physiological effects throughout the digestive system. From the ingestion of food in the oral cavity to the processing and absorption of nutrients in the intestines, nutrient chemosensing receptors signal the production and release of numerous bioactive peptides from enteroendocrine cells, such as the proglucagon-derived peptides. There has been a major emphasis on two proglucagon-derived peptides, namely GLP-1 and GLP-2, due to their apparent beneficial effect on gut structure, function, and on metabolic processes. As an incretin, GLP-1 not only enhances the effect and release of insulin on pancreatic βcells but also has been implicated in having trophic effects on the intestinal epithelium. In addition, GLP-2, the other major proglucagon-derived peptide, has potent intestinotrophic effects, such as increasing the rate of mucosal stem cell proliferation, mucosal blood flow, and fluid absorption, as well as augmenting the rate of duodenal bicarbonate secretion to improve gastric mucosal health and longevity.
SUMMARY: Understanding the mechanisms underlying nutrient chemosensing and how it relates to GLP release can further elucidate how the gut functions in response to cellular changes and disturbances. Furthermore, a more in-depth comprehension of GLP release and its tissue-specific effects will help improve the utility of GLP-1 and GLP-2 receptor agonists in clinical settings. This, in turn, should help patients suffering from intestinal failure, malabsorption, and mucosal injury.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27653163      PMCID: PMC5667561          DOI: 10.1097/MOG.0000000000000316

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  45 in total

1.  Selective novel inverse agonists for human GPR43 augment GLP-1 secretion.

Authors:  Bi-Oh Park; Seong Heon Kim; Gye Yeong Kong; Da Hui Kim; Mi So Kwon; Su Ui Lee; Mun-Ock Kim; Sungchan Cho; Sangku Lee; Hyun-Jun Lee; Sang-Bae Han; Young Shin Kwak; Sung Bae Lee; Sunhong Kim
Journal:  Eur J Pharmacol       Date:  2015-12-09       Impact factor: 4.432

Review 2.  Taste receptors of the gut: emerging roles in health and disease.

Authors:  Inge Depoortere
Journal:  Gut       Date:  2013-10-16       Impact factor: 23.059

3.  Bitter taste receptors in the wrong place: novel airway smooth muscle targets for treating asthma.

Authors:  Stephen B Liggett
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

4.  Adding Rapid-Acting Insulin or GLP-1 Receptor Agonist to Basal Insulin: Outcomes in a Community Setting.

Authors:  Mehul R Dalal; Lin Xie; Onur Baser; Andres DiGenio
Journal:  Endocr Pract       Date:  2015-01       Impact factor: 3.443

5.  Short-chain fatty acid sensing in rat duodenum.

Authors:  Yasutada Akiba; Takuya Inoue; Izumi Kaji; Masaaki Higashiyama; Kazuyuki Narimatsu; Ken-ichi Iwamoto; Masahiko Watanabe; Paul H Guth; Eli Engel; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  J Physiol       Date:  2015-02-01       Impact factor: 5.182

6.  Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.

Authors:  Johanna Iturrino; Michael Camilleri; Andres Acosta; Jessica O'Neill; Duane Burton; Jithinraj Edakkanambeth Varayil; Paula J Carlson; Alan R Zinsmeister; Ryan Hurt
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-07-28       Impact factor: 4.016

7.  Dipeptidyl peptidase IV inhibition prevents the formation and promotes the healing of indomethacin-induced intestinal ulcers in rats.

Authors:  Takuya Inoue; Masaaki Higashiyama; Izumi Kaji; Sergiy Rudenkyy; Kazuhide Higuchi; Paul H Guth; Eli Engel; Jonathan D Kaunitz; Yasutada Akiba
Journal:  Dig Dis Sci       Date:  2013-12-31       Impact factor: 3.199

8.  The Role of the Sweet Taste Receptor in Enteroendocrine Cells and Pancreatic β-Cells.

Authors:  Itaru Kojima; Yuko Nakagawa
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

9.  Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration.

Authors:  Kaori Fujiwara; Takuya Inoue; Naoki Yorifuji; Munetaka Iguchi; Taisuke Sakanaka; Ken Narabayashi; Kazuki Kakimoto; Sadaharu Nouda; Toshihiko Okada; Kumi Ishida; Yosuke Abe; Daisuke Masuda; Toshihisa Takeuchi; Shinya Fukunishi; Eiji Umegaki; Yasutada Akiba; Jonathan D Kaunitz; Kazuhide Higuchi
Journal:  J Clin Biochem Nutr       Date:  2015-01-28       Impact factor: 3.114

10.  Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion.

Authors:  Sara Edfalk; Pär Steneberg; Helena Edlund
Journal:  Diabetes       Date:  2008-06-02       Impact factor: 9.461

View more
  5 in total

1.  Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.

Authors:  Ying Wang; Haiyi Liu; Miaoyan Zheng; Yanhui Yang; Huizhu Ren; Yan Kong; Shanshan Wang; Jingyu Wang; Yingying Jiang; Juhong Yang; Chunyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-07       Impact factor: 5.555

2.  Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated Microbiota.

Authors:  Nicolas Barnich; Michael Rodrigues; Pierre Sauvanet; Caroline Chevarin; Sylvain Denis; Olivier Le Goff; Danielle Faure-Imbert; Thierry Hanh; Christian F Roques; Benoit Chassaing; Monique Alric
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

3.  The Gastroprotective Effect of Small Molecule Oligopeptides Isolated from Walnut (Juglans regia L.) against Ethanol-Induced Gastric Mucosal Injury in Rats.

Authors:  Rui Liu; Yun-Tao Hao; Na Zhu; Xin-Ran Liu; Jia-Wei Kang; Rui-Xue Mao; Chao Hou; Yong Li
Journal:  Nutrients       Date:  2020-04-18       Impact factor: 5.717

4.  Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity.

Authors:  Patricia Serradas; Agnès Ribeiro; Céline Osinski; Léa Le Gléau; Christine Poitou; Juan de Toro-Martin; Laurent Genser; Magali Fradet; Hédi Antoine Soula; Armelle Leturque; Corinne Blugeon; Laurent Jourdren; Edwige Ludiwyne Hubert; Karine Clément
Journal:  Int J Obes (Lond)       Date:  2020-10-09       Impact factor: 5.095

5.  Alterations in Gastric Mucosal Expression of Calcitonin Gene-Related Peptides, Vanilloid Receptors, and Heme Oxygenase-1 Mediate Gastroprotective Action of Carbon Monoxide against Ethanol-Induced Gastric Mucosal Lesions.

Authors:  Katarzyna Magierowska; Dagmara Wojcik; Anna Chmura; Dominik Bakalarz; Mateusz Wierdak; Slawomir Kwiecien; Zbigniew Sliwowski; Tomasz Brzozowski; Marcin Magierowski
Journal:  Int J Mol Sci       Date:  2018-09-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.